Purdue, Mundipharma exercise option for Infinity program

Purdue Pharma L.P. (Stamford, Conn.) and Mundipharma International Ltd. (Cambridge, U.K.) exercised an option for exclusive, worldwide rights to the fatty acid amide hydrolase (FAAH) pain program from...